LIMN · Liminatus Pharma, Inc. · Proposed Sales
$2.82
-0.08 (-2.59%)
At close · Oct 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the Company's assessment of going concern considerations in accordance with Financial Accounting Standards Board ("FASB") ASC 205-40, Presentation of Financial Statements—Going Concern, management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.79M
Shares
1.34M
Volume · Oct 30
12.98K
Avg daily vol (50 sessions)
31.68K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.